Auto Injectors Industry was Led by the North American Region

According to the latest market research study published by P&S Intelligence, the auto injectors market made a total revenue of USD 1,011 million in 2023, and it will propel at a rate of 14.8% in the years to come, to touch a value of USD 2640.2 million in 2030.

The key factors powering the industry expansion include the mounting requirement for the drug administration ease, growing incidence of chronic and lifestyle associated diseases, and evolving healthcare technologies.

According to the WHO, over 16 billion injections are given on a yearly basis at a global level. So, the rising need for ease and safety throughout the procedure is powering the advance of the industry.

North America is the leader of auto injectors market, and this prominent position will persist in the years to come as well. This is for the reason that the continent provides ready reimbursement for the use of autoinjectors. Furthermore, the growing occurrence of anaphylactic shock will encourage the acceptance of auto-injectors filled with epinephrine. Moreover, the two nations in the region exhibit a high awareness with regards to self-administration drug delivery devices.

The fastest growth is observed by the APAC region, chiefly as a result of the growing occurrence of diabetes. Since diabetics need normal insulin administration, auto-injectors save the trouble of seeing a medic every time and, therefore, make them independent. 

Moreover, the mounting occurrence of severe reactions as a result of food allergies is driving the requirement for epinephrine injections.

Due to the increasing occurrence of lifestyle and chronic diseases all over the world, the demand for auto injectors is on the rise. This trend wil continue in the near future as well.

Read More

Process Analyzer Market Will Reach USD 10.1 Billion By 2030

The worldwide market for process analyzers was valued at approximately USD 7.9 billion in 2023 and is expected to grow to around USD 10.1 billion by 2030, with a compound annual growth rate (CAGR) of 3.7% between 2024 and 2030.

The mounting concentration on advancing water quality and public well-being, growing water needs from sectors and people, the thriving oil & gas sector, and severe government rules on wastewater treatment are the key industry propellers. 

The optimization of procedures, fortification of assets, and compliance are the major advantages of a process analyzer. The device is mainly utilized for the equipment-aided accurate periodic measurement of the chemical and physical features of an industrial procedure. Additionally, the acceptance of AI, automation, and smart tech in the manufacturing sector is catering as a key booster factor for the industry. 

The lessening obtainability of freshwater is because of the distressed weather patterns because of the pollution-encouraged climate change. Additionally, the surge in the awareness to preserve water, implement rainwater harvesting and wastewater treatment methods, and surge in the effectiveness of water supply systems propels the industry.

MLSS analyzers, based on liquid analysis, are projected to experience the most significant growth rate during the forecast period. These types of analyzers are predominantly utilized in environmental monitoring and wastewater treatment processes. 

They play a crucial role in optimizing and monitoring processes, analyzing microorganism concentrations, and effectively breaking down waste within activated sludge. By enabling continuous monitoring, MLSS analyzers alleviate the necessity for manual sampling and laboratory tests, thereby saving time and resources for operators of wastewater treatment plants.

In 2023, on the basis of gas analyzers, oxygen analyzers produced revenue of approximately USD 3 billion. The quantity of oxygen obtainable plays a leading role in determining whether the burning of a fuel is rich or lean.

Thus, such instruments are utilized to determine the amount of this gas in boilers, furnaces, and furnaces. The key benefits of this device are fast and precise readings in high-temp and corrosive atmospheres.

Read More

North America Is Dominating Active Implantable Medical Devices Industry

The market size for active implantable medical devices was valued at USD 22.5 billion in 2023 and is projected to grow to USD 37.1 billion by 2030, with a compound annual growth rate of 7.5% from 2024 to 2030.

The occurrence of chronic illnesses is increasing, the population is rapidly aging, cardiovascular and neurological illnesses are becoming more dominant, and the implantable medicinal device tech is advancing. Apart from such reasons, the industry advance is aided by the increasing funding to develop technically advanced items, increasing acceptance of neurostimulators, and growing growth in and awareness regarding medical implants.

The rising aging population is one of the key reasons behind the development of this sector. According to the World Health Organization, 2 in 12 people worldwide will be 60 years old or more by 2030. By this time, the count of individuals who are 60 years and older will touch 1.4 billion from 1 billion in 2020. Furthermore, the number of people who are 80 years or older will triple in 2020–2050 and touch 426 million.

In 2023, the hospital category, based on end users, dominated the market. This can be credited to the huge aged population and the surging occurrence of chronic illness, the requirement for healthcare facilities is increasing. 

Hospitals face an increased influx of patients, leading to greater demand for medical equipment used in patient monitoring, treatment, and diagnosis. Additionally, hospitals often provide specialized procedures and therapies necessitating specific equipment.

In 2023, based on product, the implantable cardioverter defibrillators category was the major contributor to the market. This growth can be credited to the growing count of people with cardiovascular diseases worldwide, the growing requirement for such life-saving apparatus in developing nations, and the arrival of tech technical innovations in such devices.

Read More

Enactment of Strict Emission Regulations Driving Demand for Automotive Elastomers

The automotive elastomers market was USD 34.6 billion in 2023, and it will power at a compound annual growth rate of 5.7% by the end of this decade, to touch a value of USD 50.6 billion in 2030. 

The increasing consciousness of the numerous advantages of these materials, for example, noise and emission reduction, boost in performance, and safety enhancement will power the requirement for them.

Based on type, the thermoset elastomers category is the leader of the industry, and it will also continue like this in the years to come as well. 

The tire category has the largest share, and it will also continue like this in the years to come as well. This would be mostly because of the use of elastomers in tire making to advance the performance considerably. This is mostly because the adding of intermediates reimbursements the chemical structure of rubber by providing reliable seals, elasticity, and toughness.

The APAC automotive elastomers market is the leader of the pack and it will also continue like this in the future. The existence of key players, the availability of raw materials and labor at reduced costs, and the high acceptance of advanced technologies are driving the industry. South Korea, Japan, India, and China are not just the major automotive manufacturers in the region, but at a global level.

It is because of the growing per capita income all over the world, that the demand for automotive elastomers is on the rise. This trend will continue in the years to come as well.

Read More

Red Biotechnology's Soaring Growth in Global Healthcare

The global red biotechnology market has garnered USD 576.7 billion in revenue in 2023, and it is projected to rise at the rate of 10.8% from 2023 to 2030, to capture USD 1,172.3 billion by 2030. The development of the industry can be credited to the growing use of hereditary engineering to make biological medications and the rising need for modified medicines.

The rising research and development effort by the major biopharma companies, with strong aid from governments, propels the industry. This is itself in view of the increasing occurrence of chronic diseases and communicable illnesses, which is why businesses are increasing their research efforts for emerging new drug molecules.

According to the reports, the count of biotech patents applied per year has been rising by 28% since 1995, and there are presently over 1,500 biomolecules undergoing clinical trials.

Red biotechnology is widely used in the growth of human vaccines and antibiotics, new medications, molecular diagnostic methods, and regenerative treatments, which has been propelling the industry.

In the coming few years, biopharmaceutical production is projected to experience incredible development credited to the growing research and development activities in this field of drugs. This is mainly because of the increasing making of antibiotics and other types of biologics for chronic illnesses.

In 2023, the North American region held the largest share, approximately 55%, and the regional market is also estimated to advance at a strong CAGR during the projection period. This can be credited to the increasing occurrence of chronic, rare, and hereditary diseases, the rising number of research and development initiatives, and the high technical improvement rate in the healthcare sector of this region.

Read More

Measuring Progress Exploring the Testing and Measurement Equipment Market

The size of the testing and measurement equipment market was about USD 34.8 billion in 2023, and it will power at a rate of 4.8% by the end of this decade, to touch USD 47.9 billion by 2030.

The rising EV acceptance worldwide is consistently supporting testing tool requirement as each automobile needs widespread testing before launch. The main EV components that require to be determined in performance comprise the motor, battery, and on-board charger. Moreover, the related systems, such as charging stations, back-office systems, and telematics modules, need testing.

At present, the nation has the second largest telecom network with approximately 1.2 billion subscribers, the second-highest count of internet users, and the fastest-rising mobile app industry in the world. This is mostly because of the snowballing low prices, convenience, and promising coverage. 

Hence, the need of telecom businesses for testing solutions for their carrier networks continues to increase.

Additionally, the healthcare sector has observed significant tech interventions recently, such as the advent of wearable devices, for example smartwatches. Such devices allow the collection of health data, letting for instantaneous health monitoring and the proactive treatment of health situations before the developing of the symptoms.

Wi-Fi tech is widely used in healthcare devices and smart homes, with over 30% of the IoT connections employing it. Additionally, in 2022, over 50% of the Wi-Fi-enabled devices were making the use of the latest Wi-Fi 6 and Wi-Fi 6E. The communication amid IoT devices has become more effective because of the acceptance of these technologies, therefore leading to improved performance.

The growing electronics sector has a lot to do with the growing requirement for testing and measurement equipment market in the world.

Read More

Medical Packaging Films Industry had a Considerable Share in the Asia-Pacific Region

According to the latest market research study published by P&S Intelligence, the total size of the medical packaging films market was USD 7,904.2 million in 2023, and it will power at a rate of 6.1% by the end of this decade, to touch  a value of USD 11,752.8 million by 2030. 

The requirement for medical packaging films is widely driven by the high requirement for medical products and apparatus in response to the growing count of patients and the mounting aging populace globally, and the beginning of improved packaging solutions to offer protection to concerned products.

An increase in healthcare spending is the main growth driver for the medical and pharma industry and hence provides a boost to the requirement for numerous protective packaging materials for suitable handling of needed products from their transit to end-use.

The high investment is due to the high predisposition of governments to invest in medical infra to offer required and cutting-edge healthcare facilities to the masses, the increasing living standards, the rising aging populace, and the growing R&D actions by companies.

APAC generated a substantial value, and it will also grow at a healthy rate of 6.5% ibn the years to come. This is credited to the growing requirement for pharma, because of the augmented healthcare outlay, improved obtainability of pharma and medical devices particularly for chronic ailment treatment, the rising aging populace, the increasing occurrence of chronic ailments, and the facility of support of the government and incentives in the region.

It is because of the increasing aging population around the world, the demand for medical packaging films is on the rise. This trend will continue in the years to come as well.

Read More